ask="N/A"
ask_size="N/A"
average_daily_volume="1155340"
bid="42.55"
bid_size="500"
book_value="4.05"
change="-0.36"
change_from_200_day_moving_average="-4.08"
change_from_50_day_moving_average="1.63"
change_from_52_week_high="-12.60"
change_From_52_week_low="11.30"
change_in_percent="-0.84%"
close="42.55"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.92"
ex_dividend_date="N/A"
float_shares="85794000"
high="43.23"
high_52_weeks="55.15"
last_trade_date="2/1/2017"
last_trade_price="42.55"
last_trade_size="53808"
last_trade_time="4:00pm"
low="41.15"
low_52_weeks="31.25"
market_capitalization="3.70B"
moving_average_200_day="46.63"
moving_average_50_day="40.92"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="43.00"
pe_ratio="N/A"
peg_ratio="0.72"
percent_change_from_200_day_moving_average="-8.75%"
percent_change_from_50_day_moving_average="+3.99%"
percent_change_from_52_week_high="-22.85%"
percent_change_from_52_week_low="+36.16%"
previous_close="42.91"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.60"
price_per_sales="248.51"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.10"
stock_exchange="NMS"
symbol="NBIX"
volume="1329817"
weeks_range_52="31.25 - 55.15"
